or
forgot password
  • cancer clinical trials in memphis, TN

  • Topotecan in Treating Patients With Myelodysplastic Syndrome
    University of Tennessee, Memphis Cancer Center

    Trial Locations
    University of Tennessee, Memphis Cancer Center
    Veterans Affairs Medical Center - Memphis
    Leukemia, Myelodysplastic Syndromes
    Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer
    Veterans Affairs Medical Center - Memphis
    Memphis, Tennessee 38104
    Lung Cancer
    Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
    University of Tennessee, Memphis Cancer Center

    Trial Locations
    University of Tennessee, Memphis Cancer Center
    Veterans Affairs Medical Center - Memphis
    Metastatic Cancer
    Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
    University of Tennessee Cancer Institute
    Memphis, Tennessee 38103
    Leukemia
    Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
    Baptist Cancer Institute - Memphis at Baptist Memorial Hospital - Memphis
    Memphis, Tennessee 38146
    Breast Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    University of Tennessee, Memphis Cancer Center

    Trial Locations
    University of Tennessee, Memphis Cancer Center
    Veterans Affairs Medical Center - Memphis
    Lung Cancer
    Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
    Methodist Hospitals of Memphis
    Memphis, Tennessee 38103
    Hypercalcemia of Malignancy, Lung Cancer, Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Baptist Cancer Institute - Memphis at Baptist Memorial Hospital - Memphis
    Memphis, Tennessee 38146
    Breast Cancer
    Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
    University of Tennessee, Memphis Cancer Center

    Trial Locations
    University of Tennessee, Memphis Cancer Center
    Veterans Affairs Medical Center - Memphis
    Leukemia
    Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Carcinoma of Unknown Primary, Colorectal Cancer, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Retinoblastoma
    Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer
    CCOP - Baptist Cancer Institute
    Memphis, Tennessee 38117
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor
    Saint Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Brain and Central Nervous System Tumors
    Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
    University of Tennessee, Memphis Cancer Center

    Trial Locations
    University of Tennessee, Memphis Cancer Center
    Veterans Affairs Medical Center - Memphis
    Breast Cancer
    Capecitabine in Treating Patients With Malignant Mesothelioma
    Veterans Affairs Medical Center - Memphis
    Memphis, Tennessee 38104
    Malignant Mesothelioma
    DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Brain and Central Nervous System Tumors, Lymphoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer
    West Clinic, P.C.
    Memphis, Tennessee 38117
    Pancreatic Cancer
    Positron Emission Tomography in Determining Stage of Esophageal Cancer
    University of Tennessee, Memphis
    Memphis, Tennessee 38163
    Esophageal Cancer
    Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer
    University of Tennessee, Memphis Cancer Center

    Trial Locations
    University of Tennessee, Memphis Cancer Center
    Veterans Affairs Medical Center - Memphis
    Breast Cancer
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
    CCOP - Baptist Cancer Institute
    Memphis, Tennessee 38117
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Trastuzumab in Treating Patients With Recurrent Osteosarcoma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Sarcoma
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    CCOP - Baptist Cancer Institute

    Trial Locations
    CCOP - Baptist Cancer Institute
    University of Tennessee, Memphis Cancer Center
    Head and Neck Cancer
    Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
    Saint Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Cardiac Toxicity, Lymphoma
    Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Leukemia
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Leukemia
    S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
    Danville Radiation Therapy Center

    Trial Locations
    Danville Radiation Therapy Center
    University of Tennessee Cancer Institute
    Gastrointestinal Stromal Tumor
    Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer
    CCOP - Baptist Cancer Institute
    Memphis, Tennessee 38117
    Cervical Cancer
    Oxaliplatin in Treating Children With Advanced Solid Tumors
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Unspecified Childhood Solid Tumor, Protocol Specific
    Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases
    Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group

    Trial Locations
    Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group
    Memphis Regional Brain Tumor Center
    Metastatic Cancer
    Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer
    University of Tennessee, Memphis Cancer Center

    Trial Locations
    University of Tennessee, Memphis Cancer Center
    Veterans Affairs Medical Center - Memphis
    Lung Cancer
    Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer
    University of Tennessee Cancer Institute
    Memphis, Tennessee 38103
    Colorectal Cancer
    S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
    Danville Radiation Therapy Center

    Trial Locations
    Danville Radiation Therapy Center
    University of Tennessee Cancer Institute
    Leukemia
    Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer
    Boston Baskin Cancer Group
    Memphis, Tennessee 38104
    Breast Cancer
    flt3L in Treating Patients With Acute Myeloid Leukemia
    University of Tennessee, Memphis Cancer Center

    Trial Locations
    University of Tennessee, Memphis Cancer Center
    Veterans Affairs Medical Center - Memphis
    Leukemia